INTELLIGENT BIO SOLUTIONS INC. Equity Securities, FV-NI, Gain (Loss)
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Equity Securities, FV-NI, Gain (Loss) of $175.74 thousand for the 12-month period ending 2024-06-30, per its 10-K filed 2025-08-15.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2025-08-15
- INTELLIGENT BIO SOLUTIONS INC. equity securities, fv-ni, gain (loss) for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. equity securities, fv-ni, gain (loss) for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. equity securities, fv-ni, gain (loss) for the quarter ending 2023-12-31 was $44.49K, a 97.52% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. equity securities, fv-ni, gain (loss) for the quarter ending 2023-09-30 was $131.25K.
- INTELLIGENT BIO SOLUTIONS INC. equity securities, fv-ni, gain (loss) for fiscal 2024 was $175.74K, a 91.84% decline from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. equity securities, fv-ni, gain (loss) for fiscal 2023 was $2.15M.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $0.00 derived: sum of 2 quarters · filed 2025-08-15 | $44.49K derived: sum of 3 quarters · filed 2025-08-15 | $175.74K 10-K · filed 2025-08-15 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $44.49K derived: sum of 2 quarters · filed 2025-05-13 | $175.74K 10-Q · filed 2025-05-13 | $267.23K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $44.49K 10-Q · filed 2025-02-13 | $175.74K 10-Q · filed 2025-02-13 | $267.23K derived: sum of 3 quarters · filed 2025-02-13 | $537.01K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $131.25K 10-Q · filed 2024-11-07 | $222.74K derived: sum of 2 quarters · filed 2024-11-07 | $492.52K derived: sum of 3 quarters · filed 2024-11-07 | $2.29M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $91.49K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $361.27K derived: sum of 2 quarters · filed 2024-09-18 | $2.15M derived: sum of 3 quarters · filed 2024-09-18 | $2.15M 10-K · filed 2024-09-18 |
| 2023-03-31 | $269.79K 10-Q · filed 2024-05-08 | $2.06M derived: sum of 2 quarters · filed 2024-05-08 | $2.06M 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $1.79M 10-Q · filed 2024-02-09 | $1.79M 10-Q · filed 2024-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |